Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.74 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.74 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.74 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | SELP | P16109 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | FAAH | O00519 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | CNR1 | P21554 | 1/20 | 0.64 |
| ▸ | CNR2 | P34972 | 1/20 | 0.64 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17191662 | 1.00 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL17191661 | 1.00 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL12431704 | 1.00 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL17133158 | 1.00 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL17133154 | 1.00 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL17133162 | 1.00 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL13848215 | 1.00 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL14299186 | 1.00 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL4549108 | 1.00 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL13232110 | 1.00 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210113641-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2021-04-22 | — | — | US | disclosed |
| US-20210108198-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2021-04-15 | — | — | US | disclosed |
| US-20210100905-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2021-04-08 | — | — | US | disclosed |
| EP-3778556-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | Institute of Basic Medical Sciences, Chinese Academi of Medical Sciences (CN) | 2021-02-17 | — | — | EP | disclosed |
| EP-3604269-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | Institute of Basic Medical Sciences, Chinese Academi of Medical Sciences (CN) | 2020-02-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210100905-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | TRDMT1, SNRPE, HNRNPAB | PRKCA 2156/4885PRKCE 3670/4885PRKCQ 3130/4885 |
| US-20210113641-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | CHMP4B, EXOSC5, FIP1L1 | PRKCA 164/4885PRKCE 846/4885PRKCQ 902/4885 |
| US-20210108198-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | TRDMT1, HNRNPAB, HNRNPA1 | PRKCA 2378/4885PRKCE 3922/4885PRKCQ 3379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.